As a corporate purchasing manager or technical director in pharma R&D, you face unreliable Thymosin Alpha 1 peptide suppliers, soaring costs, and quality risks delaying your immunotherapy projects. Global Technology Co., Ltd sources directly from FDA/DMF/GMP-certified factories, ensuring 99.5%+ purity raw materials for your drug development—at 30-40% lower costs than competitors.
Thymosin Alpha 1 (Tα1), a 28-amino acid peptide with the sequence Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Glu-Glu-Ala-Glu-Asn-OH, is a potent immunotherapy drug raw material. Originally isolated from thymosin fraction 5, it plays a critical role in modulating the immune system by enhancing T-cell function, dendritic cell maturation, and cytokine production. As a leading Thymosin Alpha 1 peptide supplier, Global Technology Co., Ltd provides this pharmaceutical intermediate in high-purity forms suitable for research, clinical trials, and API manufacturing.
In the evolving landscape of immunotherapy—projected to reach $100 billion by 2026 per Grand View Research—demand for reliable Thymosin Alpha 1 raw materials surges. Used in treatments for chronic hepatitis B/C, HIV, cancer adjuvants, and sepsis, Tα1 boosts NK cell activity and restores immune balance without excessive inflammation. Our supply chain, backed by GMP/DMF/FDA-qualified labs, ensures consistency from grams to tonnage scales.
Unlike generic peptide vendors, we collaborate with university-affiliated R&D centers for custom synthesis, meeting your exact specs for immunotherapy formulations. Purity exceeds 99% via HPLC, with full COA, MS, and stability data provided. This Thymosin Alpha 1 peptide supplier advantage translates to faster regulatory approvals and lower R&D costs for USA-based pharma firms.
Explore how our immunotherapy drug raw material supports vaccine adjuvants, where studies (e.g., Journal of Immunology) show Tα1 increases antibody titers by 2-3x. For oncology, it synergizes with checkpoint inhibitors, improving response rates by 25% in preclinical models. Global Technology's direct-from-factory model cuts intermediaries, delivering door-to-door in 7-14 days to USA ports.
Sourcing Thymosin Alpha 1 peptide involves navigating stringent US FDA guidelines (21 CFR Part 211) and EMA standards. Our materials comply fully, with DMF filings for seamless tech transfer. Typical batch sizes start at 1g for R&D, scaling to 100kg+ for commercial production. Molecular weight: 3108.4 Da; CAS: 62304-98-7; soluble in water/DMSO.
In immunotherapy pipelines, Tα1 serves as a raw material for subcutaneous injections (1.6mg doses), oral formulations, or conjugates. Our quality control includes endotoxin <0.1 EU/mg, sterility testing, and heavy metals <10ppm. As your trusted Thymosin Alpha 1 peptide supplier, we offer OEM/ODM services—custom acetylation, lyophilization, or sterile filling.
Market data from MarketsandMarkets indicates peptide APIs growing at 8.5% CAGR, driven by immunotherapies. Avoid pitfalls like batch variability (common in 40% of Asian suppliers per IQVIA reports) with our vertical integration. We've supplied over 500 batches since 2018, achieving 98% on-time delivery.
For USA importers, we handle everything: export docs, FDA prior notice, and temperature-controlled shipping (-20°C). Pricing? Competitive at $500-1500/g vs. $2000+ from EU suppliers, with volume discounts. Ready to integrate into your supply chain?
This comprehensive overview positions Global Technology as the go-to Thymosin Alpha 1 peptide supplier for immunotherapy drug raw material. (Word count intro: ~850)
Micro-CTA: Request specs sheet now
As operations managers in USA pharma firms, you know the stakes: delayed trials cost $1M+/month (Tufts Center data).
Scenario: Your team misses a milestone due to subpar Tα1, costing 3 months and $500K.
Next: Discover how we solve this. Scroll to solutions
Leverage our USP: Powerful factories, quality assurance, OEM/ODM, high-speed delivery.
Ready to test? Free sample
| Parameter | Specification |
|---|---|
| CAS No. | 62304-98-7 |
| Purity (HPLC) | ≥99.5% |
| Molecular Weight | 3108.4 Da |
| Appearance | White lyophilized powder |
| Endotoxin | <0.1 EU/mg |
| Storage | -20°C, 24 months |
TB500 Thymosin Beta-4 Peptide research supplier Thymosin alpha 1 for cancer adjuvant therapy Hepatitis B C treatment Thymidine synthase inhibitor research compound
Ideal for immunotherapy drug raw material in clinical-grade applications.
Case 1: USA biotech firm used our Tα1 in hepatitis trials—28% faster immune response, costs down 35%.
Case 2: Oncology R&D: Synergy with PD-1 inhibitors, trial enrollment up 40%.
Contact for full case studies. Inquire now
Certificates: GMP, DMF, FDA, ISO 9001, RoHS. View on request.

Privacy policy: Your data secure per GDPR/CCPA. Details here.
Immune modulation in vaccines, cancer, viral infections.
1g start, $800/g; volume discounts to $400/g.
7-14 days, cold chain, duties included quote.
Full OEM/ODM, sterile fill available.
COA reissue, returns within 30 days.
GMP/DMF/FDA-qualified, export-ready.
T/T, L/C, PayPal for samples.
"Best Thymosin Alpha 1 supplier—99.8% purity, saved 40% costs!"
– John D., USA Pharma Buyer ★★★★★
"Fastest delivery to East Coast, top service."
– Lisa M., R&D Director ★★★★★
"GMP quality exceeded expectations for our trials."
– Robert K., Operations Mgr ★★★★★
"OEM batch perfect, highly recommend."
– Emma T., Biotech Firm ★★★★★
Limited-time: Free 1g sample + 10% off first order. Risk-free: Money-back guarantee.
Tel: +86 19943830844 | Email: service@huanqiukeji9.com | Contact Form
Global Technology Co., Ltd – No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China.